ES2229733T3 - Dispositivo para insertar en la nariz humana. - Google Patents
Dispositivo para insertar en la nariz humana.Info
- Publication number
- ES2229733T3 ES2229733T3 ES99932616T ES99932616T ES2229733T3 ES 2229733 T3 ES2229733 T3 ES 2229733T3 ES 99932616 T ES99932616 T ES 99932616T ES 99932616 T ES99932616 T ES 99932616T ES 2229733 T3 ES2229733 T3 ES 2229733T3
- Authority
- ES
- Spain
- Prior art keywords
- basic element
- nasal
- nose
- pharmaceutical active
- active ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004480 active ingredient Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 20
- 239000011159 matrix material Substances 0.000 claims description 11
- 238000003745 diagnosis Methods 0.000 claims description 8
- 230000010352 nasal breathing Effects 0.000 claims description 7
- 230000008719 thickening Effects 0.000 claims description 6
- 239000000969 carrier Substances 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 3
- 239000011149 active material Substances 0.000 claims description 2
- 210000001331 nose Anatomy 0.000 description 13
- 239000013566 allergen Substances 0.000 description 9
- 210000002850 nasal mucosa Anatomy 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- -1 polysiloxanes Polymers 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- JPRXYLQNJJVCMZ-UHFFFAOYSA-N Rizatriptan benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C2C(CC[NH+](C)C)=CNC2=CC=C1CN1C=NC=N1 JPRXYLQNJJVCMZ-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical class C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229960005254 naratriptan Drugs 0.000 description 1
- UNHGSHHVDNGCFN-UHFFFAOYSA-N naratriptan Chemical compound C=12[CH]C(CCS(=O)(=O)NC)=CC=C2N=CC=1C1CCN(C)CC1 UNHGSHHVDNGCFN-UHFFFAOYSA-N 0.000 description 1
- 210000002184 nasal cartilage Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000013573 pollen allergen Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229940070721 polyacrylate Drugs 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960004789 rizatriptan benzoate Drugs 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229960003708 sumatriptan Drugs 0.000 description 1
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/01—Orthopaedic devices, e.g. long-term immobilising or pressure directing devices for treating broken or deformed bones such as splints, casts or braces
- A61F5/08—Devices for correcting deformities of the nose ; Devices for enlarging the nostril, e.g. for breathing improvement
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Otolaryngology (AREA)
- Nursing (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Portable Nailing Machines And Staplers (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE29807851U | 1998-04-30 | ||
| DE29807851U DE29807851U1 (de) | 1998-04-30 | 1998-04-30 | Vorrichtung zur Verbesserung der Nasenatmung |
| DE19832205 | 1998-07-17 | ||
| DE19832205 | 1998-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2229733T3 true ES2229733T3 (es) | 2005-04-16 |
Family
ID=26047505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99932616T Expired - Lifetime ES2229733T3 (es) | 1998-04-30 | 1999-04-30 | Dispositivo para insertar en la nariz humana. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6626172B1 (enExample) |
| EP (1) | EP1075294B1 (enExample) |
| JP (1) | JP4039807B2 (enExample) |
| AT (1) | ATE277659T1 (enExample) |
| AU (1) | AU744058B2 (enExample) |
| CA (1) | CA2330301C (enExample) |
| DE (2) | DE19980731D2 (enExample) |
| ES (1) | ES2229733T3 (enExample) |
| IS (1) | IS2237B (enExample) |
| WO (1) | WO1999055404A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002301153A (ja) * | 2001-04-04 | 2002-10-15 | Keytron:Kk | 呼吸補助具 |
| US20030086825A1 (en) * | 2001-11-02 | 2003-05-08 | Brennan H. George | Nose airway device for detecting airborne contaminants |
| US20050199245A1 (en) * | 2001-11-02 | 2005-09-15 | Brennan H. G. | Nose airway for aromatherapy and detecting airborne pathogens |
| US6863066B2 (en) | 2002-01-28 | 2005-03-08 | Ronald Jack Ogle | Adjustable nasal dilator filter |
| WO2005018506A1 (en) * | 2003-08-21 | 2005-03-03 | Nils Billy Nilson | Nasal device and method therefor |
| US7806120B2 (en) | 2004-12-08 | 2010-10-05 | Ventus Medical, Inc. | Nasal respiratory devices for positive end-expiratory pressure |
| US9833354B2 (en) | 2004-12-08 | 2017-12-05 | Theravent, Inc. | Nasal respiratory devices |
| ZA200808724B (en) | 2004-12-08 | 2009-11-25 | Ventus Medical Inc | Respiratory device and methods of use |
| US10610228B2 (en) | 2004-12-08 | 2020-04-07 | Theravent, Inc. | Passive nasal peep devices |
| US7947076B2 (en) | 2005-06-03 | 2011-05-24 | Medtronic Xomed, Inc. | Nasal valve treatment method and apparatus |
| GB0606669D0 (en) * | 2006-04-03 | 2006-05-10 | Stewart Keith | Nasal Dilator |
| AU2007267970B2 (en) | 2006-05-23 | 2011-05-26 | Ventus Medical, Inc. | Nasal respiratory devices |
| GB0610171D0 (en) | 2006-05-23 | 2006-06-28 | Robitaille Jean Pierre | Valved nasal canula |
| WO2007146207A2 (en) | 2006-06-07 | 2007-12-21 | Ventus Medical, Inc. | Nasal devices |
| US8240309B2 (en) * | 2006-11-16 | 2012-08-14 | Ventus Medical, Inc. | Adjustable nasal devices |
| US20080247214A1 (en) * | 2007-04-03 | 2008-10-09 | Klaus Ufert | Integrated memory |
| WO2008139002A1 (es) * | 2007-05-14 | 2008-11-20 | Munoz Franke Carlos | Dilatador nasal oculto de vía integral |
| US8020700B2 (en) | 2007-12-05 | 2011-09-20 | Ventus Medical, Inc. | Packaging and dispensing nasal devices |
| WO2009117012A1 (en) | 2008-03-17 | 2009-09-24 | Ventus Medical, Inc. | Adhesive nasal respiratory devices |
| EP2145643A1 (de) * | 2008-07-19 | 2010-01-20 | Markus Storz | Portioniertes Arzneimittel |
| US20100163048A1 (en) * | 2008-12-29 | 2010-07-01 | Owel Siordia | Nose filters |
| US8875711B2 (en) | 2010-05-27 | 2014-11-04 | Theravent, Inc. | Layered nasal respiratory devices |
| US20140336488A1 (en) * | 2011-09-14 | 2014-11-13 | The Ohio State University | Devices and methods for the rapid and accurate diagnosis and treatment of sinusitis |
| CA2850156C (en) | 2011-09-29 | 2022-08-16 | Trudell Medical International | Nasal insert and cannula and methods for the use thereof |
| US8998986B1 (en) | 2013-07-05 | 2015-04-07 | Zdzislaw B. Malinowski | Nasal stent |
| US10921320B2 (en) | 2015-03-30 | 2021-02-16 | Entvantage Diagnostics, Inc. | Devices and methods for diagnosis of sinusitis |
| US11650213B2 (en) | 2015-03-30 | 2023-05-16 | Entvantage Diagnostics, Inc. | Devices and assays for diagnosis of viral and bacterial infections |
| SI3075862T1 (en) | 2015-03-30 | 2018-02-28 | Entvantage Diagnostics, Inc. | Aids and tests for the diagnosis of sinusitis |
| US10525227B1 (en) | 2015-09-10 | 2020-01-07 | Stock IP Holdings LLC | Nasal EPAP dilator |
| EP4164550A4 (en) | 2020-06-10 | 2024-06-19 | The Board of Trustees of the Leland Stanford Junior University | Systems and methods for altering the shape of nasal tissues |
| IL305841A (en) * | 2021-03-15 | 2023-11-01 | Nat Univ Singapore | Nasal implants and methods for producing nasal implants |
| WO2024124253A1 (en) | 2022-12-09 | 2024-06-13 | Spirair, Inc. | Devices, systems, and methods for manipulating nasal tissues |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR407679A (fr) * | 1909-10-07 | 1910-03-08 | Paul Louis Henri Helot | Appareil destiné à servir d'inhalateur permanent et invisible extérieurement |
| US1839606A (en) | 1930-02-17 | 1932-01-05 | George A Simmons | Distender for nostrils |
| FR1001434A (fr) * | 1946-05-08 | 1952-02-25 | Dispositif formant support de substances médicamenteuses | |
| US3935859A (en) | 1974-09-16 | 1976-02-03 | Doyle Donald E | Surgical nasal splint |
| FR2419711A1 (fr) * | 1978-03-13 | 1979-10-12 | Gardin Andre | Dispositif destine a etre introduit a l'interieur des narines afin d'en permettre l'elargissement |
| US4201217A (en) * | 1978-07-12 | 1980-05-06 | Slater Robert L | Nostril expander |
| US5855908A (en) * | 1984-05-01 | 1999-01-05 | University Of Utah Research Foundation | Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient |
| GB8627600D0 (en) * | 1986-11-19 | 1986-12-17 | Petruson B | Nasal device |
| SE508737C2 (sv) | 1995-03-03 | 1998-11-02 | Owe Edmark | Anordning för att underlätta andning genom näsan |
| JP3020186U (ja) | 1995-07-05 | 1996-01-19 | 宏 木村 | 呼吸補助具 |
-
1999
- 1999-04-30 DE DE19980731T patent/DE19980731D2/de not_active Expired - Lifetime
- 1999-04-30 JP JP2000545599A patent/JP4039807B2/ja not_active Expired - Fee Related
- 1999-04-30 AU AU48955/99A patent/AU744058B2/en not_active Ceased
- 1999-04-30 US US09/674,385 patent/US6626172B1/en not_active Expired - Lifetime
- 1999-04-30 CA CA002330301A patent/CA2330301C/en not_active Expired - Fee Related
- 1999-04-30 ES ES99932616T patent/ES2229733T3/es not_active Expired - Lifetime
- 1999-04-30 AT AT99932616T patent/ATE277659T1/de not_active IP Right Cessation
- 1999-04-30 WO PCT/DE1999/001332 patent/WO1999055404A1/de not_active Ceased
- 1999-04-30 DE DE59910667T patent/DE59910667D1/de not_active Expired - Lifetime
- 1999-04-30 EP EP99932616A patent/EP1075294B1/de not_active Expired - Lifetime
-
2000
- 2000-10-27 IS IS5692A patent/IS2237B/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE277659T1 (de) | 2004-10-15 |
| AU744058B2 (en) | 2002-02-14 |
| IS5692A (is) | 2000-10-27 |
| US6626172B1 (en) | 2003-09-30 |
| EP1075294A1 (de) | 2001-02-14 |
| JP4039807B2 (ja) | 2008-01-30 |
| JP2002512860A (ja) | 2002-05-08 |
| CA2330301C (en) | 2007-09-25 |
| EP1075294B1 (de) | 2004-09-29 |
| DE19980731D2 (de) | 2001-05-10 |
| AU4895599A (en) | 1999-11-16 |
| WO1999055404A1 (de) | 1999-11-04 |
| DE59910667D1 (de) | 2004-11-04 |
| IS2237B (is) | 2007-05-15 |
| CA2330301A1 (en) | 1999-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2229733T3 (es) | Dispositivo para insertar en la nariz humana. | |
| US5931852A (en) | Nose airway device | |
| US8491622B2 (en) | Multi-layer internal nasal dilator with tubular expanders and compound delivery protrusions | |
| US9333329B2 (en) | Vaginal carrier for the controlled release of substances | |
| US20110015612A1 (en) | Implantable devices for treatment of sinusitis | |
| US20170273626A1 (en) | Nasal insert having one or more sensors | |
| EP2845621A3 (en) | Implantable devices for delivering drugs and other substances to treat sinusitis and other disorders | |
| EP2444038A3 (en) | Devices for deployment into a lumen | |
| BRPI0906317B1 (pt) | sistema intrauterino para períodos longos de inserção dentro da cavidade uterina e método para fabricar um sistema intrauterino | |
| US8348901B2 (en) | Nasal device and method of positioning nasogastric tubing within a patient | |
| US11400244B2 (en) | Nasal device for treatment | |
| US10525240B1 (en) | Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system | |
| TWI875808B (zh) | 用於在使用者之口腔中分配液體之咬嘴、液體分配系統和咬嘴總成 | |
| CN114403811A (zh) | 阴道给药和/或诊断系统 | |
| US20160001051A1 (en) | Method of drug delivery for ovarian cancer | |
| US20120231412A1 (en) | Oral appliance for medical treatment | |
| WO2015023479A1 (en) | Devices and systems anchored in the gastrointestinal tract | |
| TW201021863A (en) | A tracheostomy pad and a tracheostomy tube assembly with the tracheostomy pad | |
| RU2621951C1 (ru) | Внутриносовой тампон для остановки носового кровотечения из передних отделов полости носа | |
| US20220331236A1 (en) | Safer and more effective methods of transmucosal delivery for raising blood pressure | |
| RU2799546C2 (ru) | Способы лечения метастаза опухоли | |
| US20190366021A1 (en) | Device for inhibiting at least partially the sense of smell | |
| Wright et al. | Dorsal nasal flap for nasal reconstruction: The alternate forehead flap | |
| BR112020020324A2 (pt) | Método e dispositivo para melhorar tratamentos tópicos para mucosite oral e outras condições orais | |
| US20130084311A1 (en) | Lingual Vestibular Dosage-form and Delivery System for Transmucosal Administration of Pharmaceutical Agents |